Toggle light / dark theme

A massive topic deserves a massive video. Rob Miles discusses ChatGPT and how it may not be dangerous, yet.

More from Rob Miles: http://bit.ly/Rob_Miles_YouTube.

The ‘Danish’ Reddit post: https://www.reddit.com/r/GPT3/comments/zb4msc/speaking_to_ch…_while_it/

Some of Rob’s own videos which are relevant:
Reward Modelling: https://www.youtube.com/watch?v=PYylPRX6z4Q
Instrumental Convergence: https://www.youtube.com/watch?v=ZeecOKBus3Q
Problems with Language Models: https://www.youtube.com/watch?v=w65p_IIp6JY

https://www.facebook.com/computerphile.
https://twitter.com/computer_phile.

This video was filmed and edited by Sean Riley.

Google is testing new artificial intelligence-powered chat products that are likely to influence a future public product launch. They include a new chatbot and a potential way to integrate it into a search engine.

The Alphabet company is working on a project under its cloud unit called “Atlas,” which is a “code red” effort to respond to ChatGPT, the large language chatbot that took the public by storm when it launched late last year.

Kevin Systrom and Mike Krieger, the co-founders of Instagram, have launched a brand new app called Artifact. This revolutionary software uses artificial intelligence (AI) technology to provide users with a personalized news feed. Currently, an invitation code is required to access the app; however, individuals can join a waitlist in order to gain early access. Systrom and Krieger left Instagram back in 2018 after working for eight years at the Facebook-owned company. Although they publicly stated that their departure was due to their desire to explore creativity and curiosity again, tensions between the two co-founders and CEO Mark Zuckerberg were also reported. Last year, the duo debuted a website dedicated to tracking the spread of COVID-19.

JWST is good at spotting very faint, very distant objects like ancient galaxies, because it views the universe in infrared light, whose wavelengths are slightly longer than the ones our unaided eyes can see. Light from distant objects, which are moving even farther away from us as the universe expands, gets stretched into those longer wavelengths.

Although this is the most recent image the JWST team has processed and released to the public, it was one of the first images the telescope actually took. During the early summer of 2022, astronomers and engineers were firing up Webb’s instruments and getting them ready to do real science observations. This stunning image of spiral galaxy LEDA 2,046,648 was part of the process of commissioning JWST’s Near-Infrared Imager and Slitless Spectrograph (which was recently out of order for two weeks thanks to a run-in with a cosmic ray).

The godfather of vaccines discussing the future of vaccinology — dr. stanley plotkin, MD.


Dr. Stanley Plotkin, MD (https://en.wikipedia.org/wiki/Stanley_Plotkin), is an American physician, scientist, and scholar, who in the 1960s, while working at Wistar Institute in Philadelphia, played a pivotal role in discovery of a vaccine against rubella virus (which is now used worldwide as a key component of the MMR vaccine), and has worked extensively on the development and application of a wide range of other vaccines including those for polio, rabies, varicella, rotavirus and cytomegalovirus (https://www.epiv.eu/).

Dr. Plotkin graduated from New York University in 1952 and obtained a medical degree at Downstate Medical Center in Brooklyn. He was a resident in pediatrics at the Children’s Hospital of Philadelphia and at the Hospital for Sick Children in London.

In 1957, Dr. Plotkin served in the Epidemic Intelligence Service of the Centers for Disease Control (CDC) of the U.S. Public Health Service for three years and then served as a member of Wistar’s active research faculty from 1960 to 1991.

Today, in addition to his emeritus appointment at Wistar, Dr. Plotkin is emeritus professor of Pediatrics at the University of Pennsylvania (https://www.med.upenn.edu/apps/faculty/index.php/g275/p1554), and works as a consultant advising vaccine manufacturers, biotechnology firms, non-profits and governments.